RecruitingNot ApplicableNCT06449430

Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version

Randomized Clinical Trial of the Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version


Sponsor

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Enrollment

270 participants

Start Date

Jul 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

External Cephalic Version (ECV) is a maneuver to modify fetal position in pregnant women with a non-cephalic presentation. Its objective is to achieve a cephalic presentation that allows for vaginal delivery with less risk than a vaginal breech delivery or a cesarean section. ECV is an effective technique to reduce the rate of cesarean sections and is recommended by the Spanish Society of Obstetrics and Gynecology (SEGO) and the World Health Organization (WHO) Cesarean Section Working Group. The WHO aims to reduce interventionism in childbirth globally and implement non-clinical measures to reduce the rate of unnecessary cesarean sections. Despite Propofol is a sedative agent commonly used by anesthesiologist in countless ambulatory procedures in obstetric anaesthesia, it has been little studied in ECV, and its effect has not been compared with other commonly used agents such as remifentanil or spinal analgesia. The Obstetric Anesthesiology Section of the Spanish Society of Anesthesiology and Resuscitation recommends the use of locoregional analgesia in ECV.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • Voluntary participation.
  • Older than 18 years.
  • Non-cephalic presentation.
  • Desire to attempt a vaginal birth.
  • Normal blood count and coagulation prior to the intervention

Exclusion Criteria14

  • Age under 18 years old.
  • Multiple gestation.
  • Cephalic presentation.
  • Risk of fetal compromise.
  • Unexplained active bleeding.
  • Absolute contraindication for vaginal delivery (Placenta Previa)
  • or more previous cesarean sections.
  • Previous myomectomy with entry into the uterine cavity
  • Maternal fever.
  • Thrombocytopenia (\<85,000 platelets).
  • Maternal spinal anomaly.
  • Intolerance or allergy to Propofol or any of its components.
  • Intolerance or allergy to bupivacaine or any of its components.
  • Contraindication for intrathecal sedation or analgesia

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSedation with propofol

Sedation with propofol

DRUGSpinal analgesia with bupivacaine

Spinal analgesia with bupivacaine


Locations(1)

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, Murcia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06449430


Related Trials